Johnson & Johnson reports 9.1% increase in sales for Q4 2025
For the entire year, sales grew by 6% to $94.2bn, and full-year earnings per share registered at $11.03.
Drug Manufacturers
DeepHow introduces PharmaCloud for pharmaceutical manufacturers
BD invests $110m to expand US prefillable syringe production
Novartis to build fourth US radioligand therapy facility in Florida
Santhera grants Agamree rights to Nxera for DMD
MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commercialisation in Japan
Formycon and Zydus sign exclusive agreement for FYB206 supply
Denali makes $275m funding agreement with Royalty Pharma
